Argentum is excited to announce a new, grassroots opportunity facilitating the use of interested and qualified Medical Reserve Corps (MRC) volunteers to provide staff support for administering COVID-19 monoclonal antibody infusions in assisted living communities and other long-term care facilities.
The Long-Term Care Infusion Support Activity (LISA) is a collaborative initiative designed and supported by six national associations, including Argentum, that have united to form the Coalition to Advance Community-Based Solutions for COVID-19. The goals of LISA are to reduce hospitalizations, preserve U.S. healthcare system capacity, and protect America’s seniors against COVID-19.
The LISA initiative includes:
- Detailed step-by-step instructions for activating the pathway and engaging with local MRC Units and partners;
- Curated online training for MRC volunteers on core topics, including infection control, long-term care facilities, COVID-19 monoclonal antibodies, and infusion therapy; and
- Hands-on refresher training for MRC volunteers at a local infusion center (if available) on IV access, infusion therapy, and managing infusion reactions.
It should be noted that local MRC units vary widely in terms of capacity, capabilities, personnel, and competing priorities. MRC units might or might not be able to satisfy requests for LISA support.
Action items for assisted living communities and/or state partners:
- Click here to review full details about the LISA initiative and pathway.
- Share this information with your community and/or corporate leadership. If you are an Argentum State Partner, please share broadly with your membership.
- If you would like to request monoclonal antibody infusion support for your community through LISA, look up contact information for the Director of your local MRC Unit(s) here (select a state, then click map location(s) for phone/email) and inquire about the availability of LISA volunteers.
For more information about this program and other options for gaining access to monoclonal antibody treatments for your community, please contact John Schulte at Argentum, (703) 298-4567, [email protected].
